A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS

Oropharyngeal candidiasis is the most common opportunistic infection among persons infected with human immunodeficiency virus (HIV). Use of some agents is hampered by lack of efficacy, emergence of resistance, adverse events, and need for intravenous administration. Posaconazole is an extended-spect...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Clinical infectious diseases Ročník 42; číslo 8; s. 1179
Hlavní autoři:	Vazquez, Jose A, Skiest, Daniel J, Nieto, Leopoldo, Northland, Rebeca, Sanne, Ian, Gogate, Jagadish, Greaves, Wayne, Isaacs, Randi
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 15.04.2006
Témata:	Adult Aged AIDS-Related Opportunistic Infections - drug therapy Antifungal Agents - therapeutic use Candida - classification Candida - isolation & purification Candidiasis - drug therapy Candidiasis, Oral - drug therapy Double-Blind Method Ethnic Groups Female Fluconazole - therapeutic use Humans Male Microbial Sensitivity Tests Middle Aged Pharyngeal Diseases - drug therapy Pharyngeal Diseases - microbiology Probability Treatment Outcome Triazoles - pharmacology Triazoles - therapeutic use
ISSN:	1537-6591, 1537-6591
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!